profit from every CHF 100 of sales.
CHF 0CHF 100
Galenica
CHF 91.20+0.55% today
-4.8% in 1 year
1-year low CHF 80.451-year high CHF 102.80
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay CHF 25.09 for every CHF 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Galenica sold, what it kept, and what it did with the cash.
Sales went from CHF 3.59 billion in 2022 to CHF 4.14 billion in 2025, with CHF 181 million of profit last year.
SalesProfit
Galenica handed back 53% of the cash it generated last year.
CHF 115M
Free cash flow 2025CHF 244M
Bought back its own sharesCHF 14M
Paid as dividendsCHF 115M
Cash vs. debtCHF 116M vs. CHF 244M
Galenica vs. similar companies
Galenica grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from CHF 100 of sales | Sales growth a year | Price per CHF 1 of profit |
|---|---|---|---|
| Galenica | 25.1× · Fair price | ||
 McKesson | 26.7× · Fair price | ||
 Cencora | 44.1× · Expensive | ||
 Cardinal Health | 41.6× · Expensive | ||
 Sigma Healthcare | 63.0× · Very expensive |
AI analysis
An AI analyst reads Galenica's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 3,588 | 3,746 | 3,921 | 4,136 | |
| 985 | 1,042 | 1,087 | 1,156 | |
| 186 | 190 | 204 | 226 | |
| 294 | 307 | 337 | 352 | |
| 165 | 285 | 183 | 181 | |
| 3.32 | 5.72 | 3.67 | 3.63 | |
| 27.5% | 27.8% | 27.7% | 27.9% | |
| 5.2% | 5.1% | 5.2% | 5.5% | |
| 4.6% | 7.6% | 4.7% | 4.4% |
Balance sheet
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,613 | 2,991 | 3,071 | 3,297 |
| Cash | 94 | 116 | 130 | 116 |
| Total debt | 233 | 236 | 236 | 244 |
| Total liabilities | 1,363 | 1,516 | 1,519 | 1,812 |
| 1,246 | 1,471 | 1,549 | 1,482 | |
| 50 | 50 | 50 | 50 | |
| 11.2% | 10.2% | 10.8% | 11.6% | |
| 13.3% | 19.4% | 11.8% | 12.2% |
Cash flow
| In millions of CHF | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 237 | 226 | 265 | 300 | |
| 70 | 76 | 72 | 56 | |
| 167 | 149 | 192 | 244 | |
| Dividends paid | 105 | 110 | 110 | 115 |
| 1 | 11 | 10 | 14 | |
| 7 | 4 | 6 | 7 |
Valuation
- 25.1×
- –
- 8.31
- 3.0×
- 1.1×
- 18.6×
- 13.3×
- 5.4%
- 4.0%
- 2.5%
Profitability
- 27.9%
- 5.5%
- 4.4%
- –
- 11.6%
- 11.0%
- –
- –
- –
- –
Growth
- +4.8%
- +3.0%
- –
- –
- +0.1%
Financial health
- 0.4×
- 0.16
- –
- 17.5×
- 1.15
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 22%of 952
Bottom 38%of 883
Top 48%of 601
Bottom 30%of 888
Top 21%of 987
2.5%of the share price, paid each year
On $1,000 invested$25a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
63.6% of its profit
Room to growStretchedMore than it earns: 47.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
55No pass
Benjamin Graham
46No pass
Philip Fisher
40No pass
Peter Lynch
19No pass
Joel Greenblatt
27No pass
Charlie Munger
40No pass
Terry Smith
38No pass
Questions about Galenica
Is Galenica a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Galenica AI analysis
What does Galenica do?
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. It is in Medical Distribution, based in Bern, Switzerland, with 4,727 employees.
Does Galenica pay a dividend?
Yes. At today's price the dividend is 2.5% a year, about 64% of its yearly profit. In 2025 it paid out CHF 115 million in dividends.
Is Galenica stock halal?
Yes. Galenica passes our halal screen: its business is permitted and its debt is 5% of its market value, under the 30% limit. How we check
How has Galenica stock done over the past year?
Down 4.8% over the past twelve months, to CHF 91.20. It traded between CHF 80.45 and CHF 102.80 and is 11.3% below its high.
Who are Galenica's competitors?
The largest listed companies in the same industry are McKesson, Cencora, Cardinal Health and Sigma Healthcare. The peers table on this page compares their profit, growth and price with Galenica's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.